 |
|
Mohs Micrographic Surgery
A Pathologist's View
Juan Rosai, MD
From the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.
Arch Dermatol. 1999;135:1171-1173.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
I would like to begin this article by trying to determine what exactly it is that sets Mohs micrographic surgery (MMS) apart from any other surgical procedure carried out for the expressed purpose of removing a neoplasm, whether primary or recurrent at the local site. Because most practitioners of MMS now admit freely that the distinctiveness of MMS is not1 the type of procedure (such as the use of zinc chloride or any other form of chemosurgery),2 the type of equipment used (as implied by the reassuring statement that "most Mohs' surgeons can effectively operate with standard surgical instruments"),3 or the type of clinical indication (such as recurrent basal cell carcinoma), its claim to superiority must derive from the notion that MMS represents a "microscopically controlled" brand of surgery. That idea has been advanced by Mohs4 himself, who stated that "the unique and important feature of chemosurgery . . . [Full Text of this Article]
RELATED ARTICLES
A Systematic Review of Treatment Modalities for Primary Basal Cell Carcinomas
Monique R. T. M. Thissen, Martino H. A. Neumann, and Leo J. Schouten
Arch Dermatol. 1999;135(10):1177-1183.
ABSTRACT
| FULL TEXT
Mohs Surgery: The Informed View
Thomas W. McGovern and David J. Leffell
Arch Dermatol. 1999;135(10):1255-1259.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Mohs Surgery: The Informed View
McGovern and Leffell
Arch Dermatol 1999;135:1255-1259.
FULL TEXT
|
